Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Niuhuang Qinggan Capsule vs Shufeng Jiedu Capsule for common cold (wind-heat syndrome)
ChiCTR2200055642Phase 4Recruiting
- Sponsor
- Second Affiliated Hospital of Heilongjiang University of Chinese Medicine
- Start
- May 2021
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of niuhuang qinggan in nasopharyngitis (2 arms), sponsored by Second Affiliated Hospital of Heilongjiang University of Chinese Medicine. Primary endpoint: Temperature return time. Started May 2021; status: recruiting.
02
Drugs
niuhuang qinggan
03
Conditions
nasopharyngitis
Beyond the preview
Go deeper on ChiCTR2200055642.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200055642.